URINARY STONE COMPOSITION ANALYSIS IN PATIENTS IN THE TULA REGION
Abstract
Objective. To determine the influence of sex, age and various clinical characteristics on the urinary stones composition in patients in the Tula region.
Material and methods. A retrospective analysis of 143 patients’ clinical records was performed. The stones were classified according to the classification of the Mayo Clinic and the guidelines of the European Urological Association.
Results. In our study, there were 90 male patients, with male-to-female ratio 1.7:1. 61 stones were collected from patients aged 19-40 years, 61 from patients aged 41-60 years, 21 from patients over 60 years old. Only 9 patients had one-component stones, 92 patients were diagnosed with two-component stones, and 42 patients had three-component stones. Calcium oxalate stones (CaOx) were observed in 116 cases, calcium phosphate (CaPO) was found in 53 stones, 24 stone compositions included uric acid (UA), infection (struvite) stones amounted to 10. In male patients CaOx stones were observed in 60 cases, UA stones - 17, CaPO stones - 12, struvite stone - 1. In females, there were 31 CaOx stones, 10 UA stones, 8 CaPO, 4 infection stones.
Conclusion. This study presented a regional stone composition analysis in patients in the Tula region. The most of the urinary stones included CaOx (63.6% ), followed by stones including uric acid (16.8%), and infection (struvite) stones (7.0%).
About the Authors
M. M. Kutluev
Медицинский Центр «Консультант»
Russian Federation
Russian Federation
N. A. Grigoriev
АО «Европейский медицинский центр», «Медицинская школа EMC»
Russian Federation
Russian Federation
R. I. Safiullin
ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова»
Russian Federation
Russian Federation
References
1. Zeng G, Mai Z, Xia S, Wang Z. [et al.] Prevalence of kidney stones in China: An ultrasonography based cross-sectional study. BJU Int. 2017; 120(1): 109–116. (in Engl) DOI: 10.1111/bju.13828.
2. Hesse A, Brändle E, Wilbert D, Köhrmann KU, Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur. Urol. 2003; 44(6): 709–713. (in Engl) DOI: 10.1016/s0302-2838(03)00415-9.
3. Romero V, Akpinar H, Assimos DG. Kidney stones: A global picture of prevalence, incidence, and associated risk factors. Rev. Urol. 2010, 12 (2-3):86–96. (in Engl)
4. Chewcharat A, Curhan G. Trends in the prevalence of kidney stones in the United States from 2007 to 2016. Urolithiasis. 2021, 49(1):27–39. DOI: 10.1007/s00240-020-01210-w. Epub 2020 Sep 1. (in Engl)
5. Apolikhin OI, Sivkov AV, Komarova VA, Prosyannikov MYu, Golovanov SA, Kazachenko AV, Nikushina AA, Shaderkina VA. Urolithiasis in the Russian Federation (2005-2016). Eksperimentalnaya i klinicheskaya urologiya. 2018;(4):4-14.(in Russ).
6. Gadzhiev NK, Brovkin SS, Grigorev VE, Dmitriev VV, Malkhasyan VA [et al.] Metaphylaxis of urolithiasis: new look, modern approach, implementation in a mobile application. Urologiia. 2017;(1):124-129. DOI: 10.18565/urol.2017.1.124-129. (in Russ).
7. Lieske JC, Rule AD, Krambeck AE, Williams JC, Bergstralh EJ, Mehta RA, Moyer TP. Stone composition as a function of age and sex. Clin. J. Am. Soc. Nephrol. 2014; 9(12): 2141–2146. DOI: 10.2215/CJN.05660614. Epub 2014 Oct 2. (in Engl)
8. Siener R, Buchholz N, Daudon M, Hess B [et al.] Quality assessment of urinary stone analysis: results of a multicenter study of laboratories in Europe. PLoS ONE. 2016; 11(6):e0156606. DOI:10.1371/journal.pone.0156606. (in Engl)
9. Williams JC, Gambaro G, Rodgers A, Asplin J [et al.] Urine and stone analysis for the investigation of the renal stone former: a consensus conference. Urolithiasis. 2021; 49(1):1–16. DOI: 10.1007/s00240-020-01217-3. Epub 2020 Oct 13. (in Engl)
10. Skolarikos A, Neisius A, Petřík A, Somani B. [et al.] EAU Guidelines on Urolithiasis. EAU Guidelines Office, Arnhem, The Netherlands. 2022. http://uroweb.org/guidelines/compilations-of-all-guidelines. (in Engl)
11. Skolarikos A., Straub M., Knoll T., Sarica K. [et al.] Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur. Urol. 2015; 67(4): 750–763. DOI: 10.1016/j.eururo.2014.10.029. Epub 2014 Nov 20. (in Engl)
12. Saenko VS, Gazimiev MA, Pesegov SV, Alyaev YuG. Urinary stone disease. Part IV. Recurrence prevention for urinary stone disease. Urologiia. 2019; (2):88-96. (in Russ).
13. Zhang D, Li S, Zhang Z, Li N, Yuan X [et al.] Urinary stone composition analysis and clinical characterization of 1520 patients in central China. Sci. Rep. 2021; 11(1): 64-67. (in Engl) DOI: 10.1038/s41598-021-85723-3.
14. Shah S, Calle JC. Dietary and medical management of recurrent nephrolithiasis. Cleve Clin. J. Med. 2016; 83(6): 463-471. (in Engl) DOI: 10.3949/ccjm.83a.15089.
15. Moe OW, Abate N, Sakhaee K. Pathophysiology of uric acid nephrolithiasis. Endocrinol. Metab. Clin. N. Am. 2002; 31(4): 895–914. (in Engl) DOI: 10.1016/s0889-8529(02)00032-4.
16. Das P, Gupta G, Velu V, Awasthi R, Dua K, Malipeddi H. Formation of struvite urinary stones and approaches towards the inhibition— A review. Biomed. Pharmacother. 2017; 96:361–370. (in Engl) DOI: 10.1016/j.biopha.2017.10.015.
17. Daudon M, Doré JC, Jungers P, Lacour B. Changes in stone composition according to age and gender of patients: A multivariate epidemiological approach. J. Urol. Res. 2004; 32(3):241–247. (in Engl) DOI: 10.1007/s00240-004-0421-y.
Review
For citations:
Kutluev M.M., Grigoriev N.A., Safiullin R.I. URINARY STONE COMPOSITION ANALYSIS IN PATIENTS IN THE TULA REGION. Bashkortostan Medical Journal. 2023;18(3):32-37. (In Russ.)
Views:
23
Email this article 
